首页 > 最新文献

Cell medicine最新文献

英文 中文
Long-Expected New Start. 期待已久的新开始。
Pub Date : 2013-05-14 DOI: 10.3727/215517913X672245
H. Noguchi
On behalf of the Japan Society for Organ Preservation and Medical Biology (JSOPMB), I express my sincere appreciation to Professor Paul R. Sanberg (Department of Neurosurgery, College of Medicine, University of South Florida, FL, USA), Executive Editor of Cell Medicine, for providing us such an excellent opportunity to publish the data that were presented at the annual meeting of JSOPMB. I also thank Dr. David Eve, Associate Editor of Cell Medicine, for editing our papers in detail. I am very sure that the relationship between Cell Medicine and JSOPMB has enhanced the motivation of JSOPMB members as well as board members and will continue to do so in the future, while also encouraging young Japanese researchers to newly join this organization. Cell-based therapy is one of the most important medical fields in JSOPMB because this form of therapy can be useful for a wide range of diseases. Addressing the current problem of severe human donor organ shortage for cell therapies is a big challenge. Research on adult and embryonic stem cells and artificial cell development, in addition to the recent and rapidly evolving invention of induced pluripotent stem (iPS) cells, encourages us to address the problems confronting cell transplantation. Therefore, JSOPMB has now importantly focused on regenerative medicine in collaboration with cell biologists. One of the extremely important missions of the annual meeting of JSOPMB is to exchange new research outcomes and create new therapeutic concepts. JSOPMB always encourages and motivates young investigators. JSOPMB was started in 1974 for the study of organ preservation and developed widely in the 1990s with the participation of researchers in various fields of medicine, pharmacology, engineering, veterinary medicine, and basic science. Currently, JSOPMB has more than 400 members and is run under the direction of Dr. Takehide Asano, the current President of JSOPMB. Excellent presentations conducted at the 38th annual meeting of JSOPMB held on November 25–26, 2011, in Miyagi, Japan, under the supervision of Dr. Takashi Kondo (Professor, Department of Thoracic Surgery, Tohoku University, Miyagi, Japan) were selected and given an opportunity to be published in this special issue of Cell Medicine. Nine of these presentations are herein published in this special JSOPMB issue. Teratani and Kobayashi reviewed results from various groups using their transgenic rats for direct visualization of their tissues at the bench level and in cell transplantation research. This included studies on renal and liver injury, parkinsonian models, and nerve injury and islet isolation. Diabetes continued to be a major focus with two review papers evaluating different aspects of islet transplantation. Kataoka and Noguchi reviewed the relationship between ER stress and the pathogenesis of type 1 and type 2 diabetes and the association between islet transplantation and ER stress. Maruyama et al. reviewed autologous islet tran
我谨代表日本器官保存与医学生物学学会(JSOPMB)向《细胞医学》杂志的执行编辑Paul R. Sanberg教授(美国佛罗里达州南佛罗里达大学医学院神经外科)表示衷心的感谢,感谢他为我们提供了这样一个绝佳的机会来发表在JSOPMB年会上提交的数据。我还要感谢《细胞医学》的副主编David Eve博士对我们论文的详细编辑。我非常确信,细胞医学与JSOPMB之间的关系增强了JSOPMB成员和董事会成员的动力,并将在未来继续这样做,同时也鼓励年轻的日本研究人员加入这个组织。细胞治疗是JSOPMB中最重要的医学领域之一,因为这种形式的治疗可用于广泛的疾病。解决当前严重的人类供体器官短缺问题是一个巨大的挑战。对成体和胚胎干细胞和人工细胞发育的研究,以及最近和快速发展的诱导多能干细胞(iPS)的发明,鼓励我们解决细胞移植面临的问题。因此,JSOPMB现在与细胞生物学家合作,重点关注再生医学。JSOPMB年会的一个极其重要的任务是交流新的研究成果和创造新的治疗理念。JSOPMB一直鼓励和激励年轻的调查人员。JSOPMB成立于1974年,目的是研究器官保存,在20世纪90年代得到了医学、药理学、工程、兽医学和基础科学等各个领域的研究人员的广泛发展。目前,JSOPMB有400多名成员,并在JSOPMB现任主席浅野武雄博士的指导下运作。2011年11月25日至26日,在日本宫城举行的JSOPMB第38届年会上,在Takashi Kondo博士(日本宫城东北大学胸外科教授)的监督下,优秀的报告被选中并有机会发表在这期《细胞医学》特刊上。其中的9个演讲将在本期JSOPMB特刊中发表。Teratani和Kobayashi回顾了不同小组使用转基因大鼠在实验台上和细胞移植研究中直接可视化其组织的结果。这包括肾脏和肝脏损伤、帕金森模型、神经损伤和胰岛分离的研究。糖尿病仍然是一个主要的焦点,两篇综述论文评估了胰岛移植的不同方面。Kataoka和Noguchi综述了内质网应激与1型和2型糖尿病发病机制的关系,以及胰岛移植与内质网应激的关系。Maruyama等人回顾了自体胰岛移植。干细胞研究是一个重要的话题。有两篇关于胰腺干细胞的论文。Noguchi等人研究了小鼠胰腺干细胞的培养条件,Kuise等人研究了小鼠胰腺干细胞的分离效率。此外,Kasahara等人报道了间充质干细胞(MSCs)分泌的蛋白质组分能够激活保存的胰岛。有三篇关于肝细胞的论文。Dosen等人报道了在大鼠模型中使用暴露于电子放电的生理盐水可以减轻肝缺血再灌注损伤。Miyamoto等人合成了带正电荷的磁性纳米颗粒,并在模拟组织的HepG2球体三维模型中观察这些纳米颗粒。最后,Hsu等人的研究表明,柠檬酸磷酸葡萄糖补充Euro-Collins溶液可以促进热缺血大鼠肝脏分离的肝细胞的恢复。本期JSOPMB的主题是“期待已久的新起点”。董事会成员和我都期待着JSOPMB与细胞医学联合取得进一步进展。
{"title":"Long-Expected New Start.","authors":"H. Noguchi","doi":"10.3727/215517913X672245","DOIUrl":"https://doi.org/10.3727/215517913X672245","url":null,"abstract":"On behalf of the Japan Society for Organ Preservation and Medical Biology (JSOPMB), I express my sincere appreciation to Professor Paul R. Sanberg (Department of Neurosurgery, College of Medicine, University of South Florida, FL, USA), Executive Editor of Cell Medicine, for providing us such an excellent opportunity to publish the data that were presented at the annual meeting of JSOPMB. I also thank Dr. David Eve, Associate Editor of Cell Medicine, for editing our papers in detail. I am very sure that the relationship between Cell Medicine and JSOPMB has enhanced the motivation of JSOPMB members as well as board members and will continue to do so in the future, while also encouraging young Japanese researchers to newly join this organization. \u0000 \u0000Cell-based therapy is one of the most important medical fields in JSOPMB because this form of therapy can be useful for a wide range of diseases. Addressing the current problem of severe human donor organ shortage for cell therapies is a big challenge. Research on adult and embryonic stem cells and artificial cell development, in addition to the recent and rapidly evolving invention of induced pluripotent stem (iPS) cells, encourages us to address the problems confronting cell transplantation. Therefore, JSOPMB has now importantly focused on regenerative medicine in collaboration with cell biologists. \u0000 \u0000One of the extremely important missions of the annual meeting of JSOPMB is to exchange new research outcomes and create new therapeutic concepts. JSOPMB always encourages and motivates young investigators. JSOPMB was started in 1974 for the study of organ preservation and developed widely in the 1990s with the participation of researchers in various fields of medicine, pharmacology, engineering, veterinary medicine, and basic science. Currently, JSOPMB has more than 400 members and is run under the direction of Dr. Takehide Asano, the current President of JSOPMB. \u0000 \u0000Excellent presentations conducted at the 38th annual meeting of JSOPMB held on November 25–26, 2011, in Miyagi, Japan, under the supervision of Dr. Takashi Kondo (Professor, Department of Thoracic Surgery, Tohoku University, Miyagi, Japan) were selected and given an opportunity to be published in this special issue of Cell Medicine. Nine of these presentations are herein published in this special JSOPMB issue. \u0000 \u0000Teratani and Kobayashi reviewed results from various groups using their transgenic rats for direct visualization of their tissues at the bench level and in cell transplantation research. This included studies on renal and liver injury, parkinsonian models, and nerve injury and islet isolation. \u0000 \u0000Diabetes continued to be a major focus with two review papers evaluating different aspects of islet transplantation. Kataoka and Noguchi reviewed the relationship between ER stress and the pathogenesis of type 1 and type 2 diabetes and the association between islet transplantation and ER stress. Maruyama et al. reviewed autologous islet tran","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"5 2-3 1","pages":"43"},"PeriodicalIF":0.0,"publicationDate":"2013-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517913X672245","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69756028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human Liver Progenitor Cells for Liver Repair. 用于肝脏修复的人肝祖细胞。
Pub Date : 2013-04-29 eCollection Date: 2013-08-10 DOI: 10.3727/215517913X666459
Catherine A Lombard, Julie Prigent, Etienne M Sokal

Because of their high proliferative capacity, resistance to cryopreservation, and ability to differentiate into hepatocyte-like cells, stem and progenitor cells have recently emerged as attractive cell sources for liver cell therapy, a technique used as an alternative to orthotopic liver transplantation in the treatment of various hepatic ailments ranging from metabolic disorders to end-stage liver disease. Although stem and progenitor cells have been isolated from various tissues, obtaining them from the liver could be an advantage for the treatment of hepatic disorders. However, the techniques available to isolate these stem/progenitor cells are numerous and give rise to cell populations with different morphological and functional characteristics. In addition, there is currently no established consensus on the tests that need to be performed to ensure the quality and safety of these cells when used clinically. The purpose of this review is to describe the different types of liver stem/progenitor cells currently reported in the literature, discuss their suitability and limitations in terms of clinical applications, and examine how the culture and transplantation techniques can potentially be improved to achieve a better clinical outcome.

由于干细胞和祖细胞的高增殖能力、抗低温保存能力和分化为肝细胞样细胞的能力,它们最近成为肝细胞治疗的有吸引力的细胞来源,肝细胞治疗是一种替代原位肝移植的技术,用于治疗各种肝脏疾病,从代谢紊乱到终末期肝病。虽然干细胞和祖细胞已经从各种组织中分离出来,但从肝脏中获得它们可能是治疗肝脏疾病的一个优势。然而,可用于分离这些干细胞/祖细胞的技术很多,并且产生具有不同形态和功能特征的细胞群。此外,在临床使用时,为确保这些细胞的质量和安全性需要进行哪些测试,目前还没有达成共识。本综述的目的是描述目前文献中报道的不同类型的肝干/祖细胞,讨论它们在临床应用方面的适用性和局限性,并研究如何改进培养和移植技术以获得更好的临床结果。
{"title":"Human Liver Progenitor Cells for Liver Repair.","authors":"Catherine A Lombard, Julie Prigent, Etienne M Sokal","doi":"10.3727/215517913X666459","DOIUrl":"10.3727/215517913X666459","url":null,"abstract":"<p><p>Because of their high proliferative capacity, resistance to cryopreservation, and ability to differentiate into hepatocyte-like cells, stem and progenitor cells have recently emerged as attractive cell sources for liver cell therapy, a technique used as an alternative to orthotopic liver transplantation in the treatment of various hepatic ailments ranging from metabolic disorders to end-stage liver disease. Although stem and progenitor cells have been isolated from various tissues, obtaining them from the liver could be an advantage for the treatment of hepatic disorders. However, the techniques available to isolate these stem/progenitor cells are numerous and give rise to cell populations with different morphological and functional characteristics. In addition, there is currently no established consensus on the tests that need to be performed to ensure the quality and safety of these cells when used clinically. The purpose of this review is to describe the different types of liver stem/progenitor cells currently reported in the literature, discuss their suitability and limitations in terms of clinical applications, and examine how the culture and transplantation techniques can potentially be improved to achieve a better clinical outcome. </p>","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"5 1 1","pages":"1-16"},"PeriodicalIF":0.0,"publicationDate":"2013-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517913X666459","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69755996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Transplantation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Restores the Neurobehavioral Disorders of Rats With Neonatal Hypoxic-Ischemic Encephalopathy. 人脂肪组织源性间充质干细胞移植修复新生儿缺氧缺血性脑病大鼠神经行为障碍。
Pub Date : 2013-02-07 DOI: 10.3727/215517913X658936
Dongsun Park, S. H. Lee, Dae-Kwon Bae, Yun-Hui Yang, Goeun Yang, Jangbeen Kyung, Dajeong Kim, E. Choi, J. Hong, I. Shin, S. Kang, J. Ra, Yun-Bae Kim
Improving the effects of human adipose tissue-derived mesenchymal stem cells (ASCs) on the demyelination and neurobehavioral function was investigated in an experimental model of neonatal hypoxic-ischemic encephalopathy (HIE). Seven-day-old male rats were subjected to hypoxia-ischemia-lipopolysaccharide and intracerebroventricularly transplanted with human ASCs (4 × 10(5) cells/rat) once at postnatal day 10 (PND10) or repeatedly at PND10, 17, 27, and 37. Neurobehavioral abnormalities (at PND20, 30, and 40) and cognitive functions (at PND41-44) were evaluated using multiple test systems. Human ASCs recovered the using ratio of forelimb contralateral to the injured brain, improved locomotor activity, and restored rota-rod performance of HIE animals, in addition to showing a marked improvement of cognitive functions. It was confirmed that transplanted human ASCs migrated to injured areas and differentiated into oligodendrocytes expressing myelin basic protein (MBP). Moreover, transplanted ASCs restored production of growth and neurotrophic factors and expression of decreased inflammatory cytokines, leading to attenuation of host MBP loss. The results indicate that transplanted ASCs restored neurobehavioral functions by producing MBP as well as by preserving host myelins, which might be mediated by ASCs' anti-inflammatory activity and release of growth and neurotrophic factors.
在新生儿缺氧缺血性脑病(HIE)实验模型中,研究了改善人脂肪组织源性间充质干细胞(ASCs)对脱髓鞘和神经行为功能的影响。7日龄雄性大鼠在出生后第10天(PND10)或在PND10、17、27和37天重复进行缺氧-缺血-脂多糖和脑室内移植人ASCs (4 × 10(5)个细胞/大鼠)。使用多种测试系统评估神经行为异常(PND20、30和40)和认知功能(PND41-44)。人ASCs除显著改善认知功能外,还能恢复HIE动物对侧前肢对脑的利用率,改善运动活动,恢复旋棒运动能力。证实移植的人ASCs向损伤部位迁移并分化为表达髓鞘碱性蛋白(MBP)的少突胶质细胞。此外,移植的ASCs恢复了生长因子和神经营养因子的产生,减少了炎症因子的表达,导致宿主MBP损失的减弱。结果表明,移植的ASCs通过产生MBP和保存宿主髓磷脂来恢复神经行为功能,这可能与ASCs的抗炎活性以及生长和神经营养因子的释放有关。
{"title":"Transplantation of Human Adipose Tissue-Derived Mesenchymal Stem Cells Restores the Neurobehavioral Disorders of Rats With Neonatal Hypoxic-Ischemic Encephalopathy.","authors":"Dongsun Park, S. H. Lee, Dae-Kwon Bae, Yun-Hui Yang, Goeun Yang, Jangbeen Kyung, Dajeong Kim, E. Choi, J. Hong, I. Shin, S. Kang, J. Ra, Yun-Bae Kim","doi":"10.3727/215517913X658936","DOIUrl":"https://doi.org/10.3727/215517913X658936","url":null,"abstract":"Improving the effects of human adipose tissue-derived mesenchymal stem cells (ASCs) on the demyelination and neurobehavioral function was investigated in an experimental model of neonatal hypoxic-ischemic encephalopathy (HIE). Seven-day-old male rats were subjected to hypoxia-ischemia-lipopolysaccharide and intracerebroventricularly transplanted with human ASCs (4 × 10(5) cells/rat) once at postnatal day 10 (PND10) or repeatedly at PND10, 17, 27, and 37. Neurobehavioral abnormalities (at PND20, 30, and 40) and cognitive functions (at PND41-44) were evaluated using multiple test systems. Human ASCs recovered the using ratio of forelimb contralateral to the injured brain, improved locomotor activity, and restored rota-rod performance of HIE animals, in addition to showing a marked improvement of cognitive functions. It was confirmed that transplanted human ASCs migrated to injured areas and differentiated into oligodendrocytes expressing myelin basic protein (MBP). Moreover, transplanted ASCs restored production of growth and neurotrophic factors and expression of decreased inflammatory cytokines, leading to attenuation of host MBP loss. The results indicate that transplanted ASCs restored neurobehavioral functions by producing MBP as well as by preserving host myelins, which might be mediated by ASCs' anti-inflammatory activity and release of growth and neurotrophic factors.","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"5 1 1","pages":"17-28"},"PeriodicalIF":0.0,"publicationDate":"2013-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517913X658936","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69755920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS. 简单机械灌注可显著提高缺血和新鲜大鼠肝脏的肝细胞产量。
Pub Date : 2013-01-01 DOI: 10.3727/215517912X658927
Maria-Louisa Izamis, Candice Calhoun, Basak E Uygun, Maria Angela Guzzardi, Gavrielle Price, Martha Luitje, Nima Saeidi, Martin L Yarmush, Korkut Uygun

The scarcity of viable hepatocytes is a significant bottleneck in cell transplantation, drug discovery, toxicology, tissue engineering, and bioartificial assist devices, where trillions of high-functioning hepatocytes are needed annually. We took the novel approach of using machine perfusion to maximize cell recovery, specifically from uncontrolled cardiac death donors, the largest source of disqualified donor organs. In a rat model, we developed a simple 3 hour room temperature (20±2°C) machine perfusion protocol to treat non-premedicated livers exposed to 1 hour of warm (34°C) ischemia. Treated ischemic livers were compared to fresh, fresh-treated and untreated ischemic livers using viable hepatocyte yields and in vitro performance as quantitative endpoints. Perfusion treatment resulted in both a 25-fold increase in viable hepatocytes from ischemic livers, and a 40% increase from fresh livers. While cell morphology and function in suspension and plate cultures of untreated warm ischemic cells was significantly impaired, treated warm ischemic cells were indistinguishable from fresh hepatocytes. Further, a strong linear correlation between tissue ATP and cell yield enabled accurate evaluation of the extent of perfusion recovery. Maximal recovery of warm ischemic liver ATP content appears to be correlated with optimal flow through the microvasculature. These data demonstrate that the inclusion of a simple perfusion-preconditioning step can significantly increase the efficiency of functional hepatocyte yields and the number of donor livers that can be gainfully utilized.

在细胞移植、药物发现、毒理学、组织工程和生物人工辅助装置等领域,每年需要数万亿个高功能肝细胞,而活肝细胞的缺乏是一个重大瓶颈。我们采用了一种新颖的方法,使用机器灌注来最大化细胞恢复,特别是来自不受控制的心脏死亡供体,这是不合格供体器官的最大来源。在大鼠模型中,我们建立了一个简单的3小时室温(20±2°C)机器灌注方案来治疗暴露于1小时热(34°C)缺血的未预用药肝脏。用活肝细胞产量和体外性能作为定量终点,将治疗过的缺血性肝脏与新鲜、新鲜治疗和未治疗的缺血性肝脏进行比较。灌注治疗使缺血肝脏的活肝细胞增加25倍,新鲜肝脏的活肝细胞增加40%。虽然未处理的热缺血细胞悬浮培养和平板培养的细胞形态和功能明显受损,但处理过的热缺血细胞与新鲜肝细胞无法区分。此外,组织ATP与细胞产量之间存在很强的线性相关性,可以准确评估灌注恢复的程度。热缺血肝脏ATP含量的最大恢复似乎与微血管的最佳流量有关。这些数据表明,包含一个简单的灌注预处理步骤可以显著提高功能性肝细胞产量的效率和可以有效利用的供肝数量。
{"title":"SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS.","authors":"Maria-Louisa Izamis, Candice Calhoun, Basak E Uygun, Maria Angela Guzzardi, Gavrielle Price, Martha Luitje, Nima Saeidi, Martin L Yarmush, Korkut Uygun","doi":"10.3727/215517912X658927","DOIUrl":"10.3727/215517912X658927","url":null,"abstract":"<p><p>The scarcity of viable hepatocytes is a significant bottleneck in cell transplantation, drug discovery, toxicology, tissue engineering, and bioartificial assist devices, where trillions of high-functioning hepatocytes are needed annually. We took the novel approach of using machine perfusion to maximize cell recovery, specifically from uncontrolled cardiac death donors, the largest source of disqualified donor organs. In a rat model, we developed a simple 3 hour room temperature (20±2°C) machine perfusion protocol to treat non-premedicated livers exposed to 1 hour of warm (34°C) ischemia. Treated ischemic livers were compared to fresh, fresh-treated and untreated ischemic livers using viable hepatocyte yields and <i>in vitro</i> performance as quantitative endpoints. Perfusion treatment resulted in both a 25-fold increase in viable hepatocytes from ischemic livers, and a 40% increase from fresh livers. While cell morphology and function in suspension and plate cultures of untreated warm ischemic cells was significantly impaired, treated warm ischemic cells were indistinguishable from fresh hepatocytes. Further, a strong linear correlation between tissue ATP and cell yield enabled accurate evaluation of the extent of perfusion recovery. Maximal recovery of warm ischemic liver ATP content appears to be correlated with optimal flow through the microvasculature. These data demonstrate that the inclusion of a simple perfusion-preconditioning step can significantly increase the efficiency of functional hepatocyte yields and the number of donor livers that can be gainfully utilized.</p>","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"4 3","pages":"109-123"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517912X658927","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32843227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds. 同种异体角化细胞和成纤维细胞在纤维蛋白基质中应用于急性全层伤口的细胞持久性。
Pub Date : 2013-01-01 DOI: 10.3727/215517912X653346
J. Dickerson, J. Planz, B. Reece, Kathy A Weedon, Sandy D Kirkpatrick, H. Slade
HP802-247 is a living cell suspension of cultured allogeneic growth-arrested human male keratinocytes and fibroblasts (1:9 ratio), intended for spray application to chronic wounds. In this study, a small wound was created on the arms of 28 healthy female volunteers (3-mm punch), followed by a single application of HP802-247. At each subsequent week for 8 weeks, a punch excision of the wounds was performed on a cohort of three subjects. Excised specimens were analyzed for allogeneic fibroblast and keratinocyte DNA determined by Y-chromosome short-tandem repeats using PCR amplification followed by capillary electrophoresis, a method with estimated sensitivity of 1 male cell in a background of 8,000 female cells. A complete haplotype attributable to HP802-247 fibroblasts was detected in three of three samples at 1 week, with one partial and one complete fibroblast haplotype detected at 2 weeks, and one partial keratinocyte haplotype detected at 3 weeks postapplication. The findings indicate that HP802-247 can be expected to persist in an acute wound bed for up to 2 weeks postapplication.
HP802-247是一种培养的异基因生长阻滞的人类男性角质形成细胞和成纤维细胞(1:9比例)的活细胞悬液,用于慢性伤口喷雾。在这项研究中,在28名健康女性志愿者的手臂上留下一个小伤口(3毫米的穿孔),然后使用HP802-247。在随后的每一周,连续8周,对3名受试者进行伤口穿孔切除。对切除标本进行异体成纤维细胞和角化细胞DNA的分析,采用y染色体短串联重复序列进行PCR扩增,然后进行毛细管电泳,该方法在8,000个女性细胞背景中估计敏感性为1个男性细胞。1周时在3个样本中检测到可归因于HP802-247成纤维细胞的完整单倍型,2周时检测到一个部分和一个完整成纤维细胞单倍型,应用后3周检测到一个部分角质形成细胞单倍型。研究结果表明,HP802-247可以在急性伤口床上持续使用长达2周。
{"title":"Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds.","authors":"J. Dickerson, J. Planz, B. Reece, Kathy A Weedon, Sandy D Kirkpatrick, H. Slade","doi":"10.3727/215517912X653346","DOIUrl":"https://doi.org/10.3727/215517912X653346","url":null,"abstract":"HP802-247 is a living cell suspension of cultured allogeneic growth-arrested human male keratinocytes and fibroblasts (1:9 ratio), intended for spray application to chronic wounds. In this study, a small wound was created on the arms of 28 healthy female volunteers (3-mm punch), followed by a single application of HP802-247. At each subsequent week for 8 weeks, a punch excision of the wounds was performed on a cohort of three subjects. Excised specimens were analyzed for allogeneic fibroblast and keratinocyte DNA determined by Y-chromosome short-tandem repeats using PCR amplification followed by capillary electrophoresis, a method with estimated sensitivity of 1 male cell in a background of 8,000 female cells. A complete haplotype attributable to HP802-247 fibroblasts was detected in three of three samples at 1 week, with one partial and one complete fibroblast haplotype detected at 2 weeks, and one partial keratinocyte haplotype detected at 3 weeks postapplication. The findings indicate that HP802-247 can be expected to persist in an acute wound bed for up to 2 weeks postapplication.","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"4 3 1","pages":"149-52"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517912X653346","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69755804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Human Decidua-Derived Mesenchymal Cells Are a Promising Source for the Generation and Cell Banking of Human Induced Pluripotent Stem Cells. 人蜕膜间充质细胞是人类诱导多能干细胞的重要来源。
Pub Date : 2012-11-01 DOI: 10.3727/215517912X658918
T. Shofuda, D. Kanematsu, H. Fukusumi, A. Yamamoto, Yohei Bamba, S. Yoshitatsu, H. Suemizu, Masato Nakamura, Y. Sugimoto, M. Furue, A. Kohara, W. Akamatsu, Y. Okada, H. Okano, M. Yamasaki, Y. Kanemura
Placental tissue is a biomaterial with remarkable potential for use in regenerative medicine. It has a three-layer structure derived from the fetus (amnion and chorion) and the mother (decidua), and it contains huge numbers of cells. Moreover, placental tissue can be collected without any physical danger to the donor and can be matched with a variety of HLA types. The decidua-derived mesenchymal cells (DMCs) are highly proliferative fibroblast-like cells that express a similar pattern of CD antigens as bone marrow-derived mesenchymal cells (BM-MSCs). Here we demonstrated that induced pluripotent stem (iPS) cells could be efficiently generated from DMCs by retroviral transfer of reprogramming factor genes. DMC-hiPS cells showed equivalent characteristics to human embryonic stem cells (hESCs) in colony morphology, global gene expression profile (including human pluripotent stem cell markers), DNA methylation status of the OCT3/4 and NANOG promoters, and ability to differentiate into components of the three germ layers in vitro and in vivo. The RNA expression of XIST and the methylation status of its promoter region suggested that DMC-iPSCs, when maintained undifferentiated and pluripotent, had three distinct states: (1) complete X-chromosome reactivation, (2) one inactive X-chromosome, or (3) an epigenetic aberration. Because DMCs are derived from the maternal portion of the placenta, they can be collected with the full consent of the adult donor and have considerable ethical advantages for cell banking and the subsequent generation of human iPS cells for regenerative applications.
胎盘组织是一种具有显著再生医学潜力的生物材料。它是由胎儿(羊膜和绒毛膜)和母体(蜕膜)形成的三层结构,含有大量的细胞。此外,收集胎盘组织对供体没有任何身体危险,并且可以与多种HLA类型匹配。蜕膜源性间充质细胞(DMCs)是高度增殖的成纤维细胞样细胞,表达与骨髓源性间充质细胞(BM-MSCs)相似的CD抗原模式。本研究证明,通过逆转录病毒转移重编程因子基因,可以有效地从dmc中产生诱导多能干细胞(iPS)。DMC-hiPS细胞在集落形态、整体基因表达谱(包括人类多能干细胞标记)、OCT3/4和NANOG启动子的DNA甲基化状态以及在体外和体内分化为三种胚层成分的能力方面与人胚胎干细胞(hESCs)具有相当的特征。XIST的RNA表达及其启动子区的甲基化状态表明,DMC-iPSCs在保持未分化和多能性时,有三种不同的状态:(1)完全的x染色体再激活,(2)一条失活的x染色体,或(3)表观遗传畸变。由于dmc来自胎盘的母体部分,因此可以在成年供体完全同意的情况下收集它们,并且对于细胞库和后续一代用于再生应用的人类iPS细胞具有相当大的伦理优势。
{"title":"Human Decidua-Derived Mesenchymal Cells Are a Promising Source for the Generation and Cell Banking of Human Induced Pluripotent Stem Cells.","authors":"T. Shofuda, D. Kanematsu, H. Fukusumi, A. Yamamoto, Yohei Bamba, S. Yoshitatsu, H. Suemizu, Masato Nakamura, Y. Sugimoto, M. Furue, A. Kohara, W. Akamatsu, Y. Okada, H. Okano, M. Yamasaki, Y. Kanemura","doi":"10.3727/215517912X658918","DOIUrl":"https://doi.org/10.3727/215517912X658918","url":null,"abstract":"Placental tissue is a biomaterial with remarkable potential for use in regenerative medicine. It has a three-layer structure derived from the fetus (amnion and chorion) and the mother (decidua), and it contains huge numbers of cells. Moreover, placental tissue can be collected without any physical danger to the donor and can be matched with a variety of HLA types. The decidua-derived mesenchymal cells (DMCs) are highly proliferative fibroblast-like cells that express a similar pattern of CD antigens as bone marrow-derived mesenchymal cells (BM-MSCs). Here we demonstrated that induced pluripotent stem (iPS) cells could be efficiently generated from DMCs by retroviral transfer of reprogramming factor genes. DMC-hiPS cells showed equivalent characteristics to human embryonic stem cells (hESCs) in colony morphology, global gene expression profile (including human pluripotent stem cell markers), DNA methylation status of the OCT3/4 and NANOG promoters, and ability to differentiate into components of the three germ layers in vitro and in vivo. The RNA expression of XIST and the methylation status of its promoter region suggested that DMC-iPSCs, when maintained undifferentiated and pluripotent, had three distinct states: (1) complete X-chromosome reactivation, (2) one inactive X-chromosome, or (3) an epigenetic aberration. Because DMCs are derived from the maternal portion of the placenta, they can be collected with the full consent of the adult donor and have considerable ethical advantages for cell banking and the subsequent generation of human iPS cells for regenerative applications.","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"4 3 1","pages":"125-47"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517912X658918","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69755865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Higher Sensitivity of Peripheral Blood Lymphocytes to Endogenous Glucocorticoid in Renal Transplant Recipients Treated With Tacrolimus, as Compared to Those Treated With Cyclosporine. 与环孢素相比,他克莫司治疗的肾移植受者外周血淋巴细胞对内源性糖皮质激素的敏感性更高。
Pub Date : 2012-11-01 DOI: 10.3727/215517912X639423
Gulimire Muhetaer, H. Takeuchi, Sogo Akizuki, H. Iwamoto, M. Shimazu, S. Unezaki, T. Hirano
Lymphocyte sensitivity to endogenous glucocorticoid cortisol could be a biological marker for safe reduction and withdrawal of steroids in renal transplant recipients. We compared peripheral lymphocyte sensitivity with cortisol between transplant recipients treated with tacrolimus (Tac) and those treated with cyclosporine. The suppressive efficacies of cortisol against T-cell mitogen-stimulated proliferation of peripheral lymphocytes were investigated in 44 renal transplant patients, who either had reduced or been withdrawn from steroid treatment. Twenty of the 44 patients were treated with Tac, and the other 24 patients were treated with cyclosporine A (CyA). The lymphocyte sensitivity to cortisol was compared between these two patient groups. The cortisol IC50 values in the Tac and CyA groups were 0.09 ± 0.12 and 14.2 ± 12.7 ng/ml, respectively. Lymphocyte sensitivity to cortisol in the Tac-treated group was significantly higher than that in the CyA-treated group (p = 0.0283). On the other hand, incidences of steroid withdrawal syndrome and increases in serum creatinine concentration were not significantly different between the Tac and CyA groups. Lymphocyte sensitivity to cortisol was higher in the Tac-treated patients than that in the CyA-treated ones. Since the cortisol sensitivity of peripheral lymphocytes is suggested to be a predictive marker for safe steroid withdrawal, Tac administration shows promise in aiding successful withdrawal of steroid treatment in long-term renal transplant recipients.
淋巴细胞对内源性糖皮质激素皮质醇的敏感性可能是肾移植受者安全减少和停用类固醇的生物学标志物。我们比较了接受他克莫司(Tac)和环孢素治疗的移植受者外周血淋巴细胞对皮质醇的敏感性。在44例肾移植患者中,研究了皮质醇对t细胞有丝分裂原刺激的外周血淋巴细胞增殖的抑制作用,这些患者要么减少了类固醇治疗,要么停止了类固醇治疗。44例患者中有20例采用Tac治疗,其余24例采用环孢素A (CyA)治疗。比较两组患者淋巴细胞对皮质醇的敏感性。Tac组和CyA组皮质醇IC50值分别为0.09±0.12和14.2±12.7 ng/ml。tac治疗组淋巴细胞对皮质醇的敏感性显著高于cya治疗组(p = 0.0283)。另一方面,类固醇戒断综合征的发生率和血清肌酐浓度升高在Tac组和CyA组之间无显著差异。taca组患者淋巴细胞对皮质醇的敏感性高于cya组。由于外周淋巴细胞的皮质醇敏感性被认为是类固醇安全停药的预测指标,Tac给药有望帮助长期肾移植受者成功停药。
{"title":"Higher Sensitivity of Peripheral Blood Lymphocytes to Endogenous Glucocorticoid in Renal Transplant Recipients Treated With Tacrolimus, as Compared to Those Treated With Cyclosporine.","authors":"Gulimire Muhetaer, H. Takeuchi, Sogo Akizuki, H. Iwamoto, M. Shimazu, S. Unezaki, T. Hirano","doi":"10.3727/215517912X639423","DOIUrl":"https://doi.org/10.3727/215517912X639423","url":null,"abstract":"Lymphocyte sensitivity to endogenous glucocorticoid cortisol could be a biological marker for safe reduction and withdrawal of steroids in renal transplant recipients. We compared peripheral lymphocyte sensitivity with cortisol between transplant recipients treated with tacrolimus (Tac) and those treated with cyclosporine. The suppressive efficacies of cortisol against T-cell mitogen-stimulated proliferation of peripheral lymphocytes were investigated in 44 renal transplant patients, who either had reduced or been withdrawn from steroid treatment. Twenty of the 44 patients were treated with Tac, and the other 24 patients were treated with cyclosporine A (CyA). The lymphocyte sensitivity to cortisol was compared between these two patient groups. The cortisol IC50 values in the Tac and CyA groups were 0.09 ± 0.12 and 14.2 ± 12.7 ng/ml, respectively. Lymphocyte sensitivity to cortisol in the Tac-treated group was significantly higher than that in the CyA-treated group (p = 0.0283). On the other hand, incidences of steroid withdrawal syndrome and increases in serum creatinine concentration were not significantly different between the Tac and CyA groups. Lymphocyte sensitivity to cortisol was higher in the Tac-treated patients than that in the CyA-treated ones. Since the cortisol sensitivity of peripheral lymphocytes is suggested to be a predictive marker for safe steroid withdrawal, Tac administration shows promise in aiding successful withdrawal of steroid treatment in long-term renal transplant recipients.","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"11 1","pages":"75-80"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517912X639423","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69755606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke. CXCR4过表达对缺血性脑卒中间充质干细胞移植的影响。
Pub Date : 2012-07-01 DOI: 10.3727/215517912X647172
O. Bang, K. S. Jin, Mi Na Hwang, H. Kang, B. Kim, Sang Jin Lee, S. Kang, Y. Hwang, J. Ahn, K. Sung
There is no doubt that the therapeutic efficacy of mesenchymal stem cells (MSCs) needs improvement. SDF-1 (chemokine for MSC homing) and its receptor CXCR4 play a critical role in the migration of MSCs in ischemia. We investigated the effects of the therapeutic application of MSCs transfected to overexpress CXCR4 using an adenoviral construct in the rat stroke model. Both flow cytometry and Western blot analysis indicated that the level of CXCR4 expression was low in naive hMSCs but was consistently high in CXCR4-hMSCs. In vivo migration test using the transwell system showed that the degree of migration was increased in CXCR4-hMSCs compared with the naive hMSCs and was completely blocked by treatment with AMD3100, an antagonist of the CXCR4 receptor. Compared with rats that received naive MSCs, behavioral recovery was more pronounced in rats that received CXCR4-hMSCs (p = 0.023). An immunohistochemistry study using human nuclear antibody (NuMA) showed that the migration of hMSCs in the ischemic boundary zone was increased after 3 days of injection of CXCR4-hMSCs compared with after injection of naive hMSCs. In addition, polymerase chain reaction was performed to assess the biodistribution of human-specific DNA outside the brain after intravenous injection of hMSCs. The expression of human-specific DNA was increased in the lungs of rats receiving naive MSCs, whereas the human-specific DNA expression was increased in the brain of rats receiving CXCR4-hMSCs. Our results indicate that MSCs transfected with the CXCR4 gene expression cassette may be useful in the treatment of cerebral infarction and may represent a new strategy to enhance the efficacy of MSC therapy.
毫无疑问,间充质干细胞(MSCs)的治疗效果有待提高。SDF-1 (MSC homing的趋化因子)及其受体CXCR4在缺血时MSCs的迁移中起关键作用。我们利用腺病毒构建体研究了转染过表达CXCR4的间充质干细胞在大鼠中风模型中的治疗作用。流式细胞术和Western blot分析均表明,CXCR4在初始hMSCs中的表达水平较低,而在CXCR4-hMSCs中的表达水平始终较高。使用transwell系统进行的体内迁移试验表明,与未处理的hMSCs相比,CXCR4-hMSCs的迁移程度增加,并且被CXCR4受体拮抗剂AMD3100完全阻断。与未接受MSCs的大鼠相比,接受CXCR4-hMSCs的大鼠行为恢复更为明显(p = 0.023)。人核抗体(NuMA)免疫组化研究显示,与未注射hMSCs相比,注射CXCR4-hMSCs 3天后,hMSCs在缺血边界区的迁移增加。此外,采用聚合酶链反应评估静脉注射hMSCs后人类特异性DNA在脑外的生物分布。在接受初代MSCs的大鼠肺中,人类特异性DNA的表达增加,而在接受CXCR4-hMSCs的大鼠脑中,人类特异性DNA的表达增加。我们的研究结果表明,转染CXCR4基因表达盒的间充质干细胞可能有助于脑梗死的治疗,并可能代表一种提高间充质干细胞治疗疗效的新策略。
{"title":"The Effect of CXCR4 Overexpression on Mesenchymal Stem Cell Transplantation in Ischemic Stroke.","authors":"O. Bang, K. S. Jin, Mi Na Hwang, H. Kang, B. Kim, Sang Jin Lee, S. Kang, Y. Hwang, J. Ahn, K. Sung","doi":"10.3727/215517912X647172","DOIUrl":"https://doi.org/10.3727/215517912X647172","url":null,"abstract":"There is no doubt that the therapeutic efficacy of mesenchymal stem cells (MSCs) needs improvement. SDF-1 (chemokine for MSC homing) and its receptor CXCR4 play a critical role in the migration of MSCs in ischemia. We investigated the effects of the therapeutic application of MSCs transfected to overexpress CXCR4 using an adenoviral construct in the rat stroke model. Both flow cytometry and Western blot analysis indicated that the level of CXCR4 expression was low in naive hMSCs but was consistently high in CXCR4-hMSCs. In vivo migration test using the transwell system showed that the degree of migration was increased in CXCR4-hMSCs compared with the naive hMSCs and was completely blocked by treatment with AMD3100, an antagonist of the CXCR4 receptor. Compared with rats that received naive MSCs, behavioral recovery was more pronounced in rats that received CXCR4-hMSCs (p = 0.023). An immunohistochemistry study using human nuclear antibody (NuMA) showed that the migration of hMSCs in the ischemic boundary zone was increased after 3 days of injection of CXCR4-hMSCs compared with after injection of naive hMSCs. In addition, polymerase chain reaction was performed to assess the biodistribution of human-specific DNA outside the brain after intravenous injection of hMSCs. The expression of human-specific DNA was increased in the lungs of rats receiving naive MSCs, whereas the human-specific DNA expression was increased in the brain of rats receiving CXCR4-hMSCs. Our results indicate that MSCs transfected with the CXCR4 gene expression cassette may be useful in the treatment of cerebral infarction and may represent a new strategy to enhance the efficacy of MSC therapy.","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"44 1","pages":"65-76"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517912X647172","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69755472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Behavior of Human Articular Chondrocytes During In Vivo Culture in Closed, Permeable Chambers. 人关节软骨细胞在封闭、可渗透腔体内培养过程中的行为。
Pub Date : 2012-07-01 DOI: 10.3727/215517912X647226
I. Martinez-Zubiaurre, Tuija Annala, M. Polacek
The exact contribution of transplanted chondrocytes for cartilage tissue repair prior expansion in monolayer culures remains undetermined. At our laboratory, we have created a new permeable chamber to study the chondrogenesis of dedifferentiated cells implanted ectopically in a closed and controlled environment. The behavior of chondrocytes has been studied in settings frequently used in clinical approaches during transplantation, namely injection of autologous chondrocyte cells in suspension (ACI), cells soaked in collagen membranes (MACI), and cells applied in a polymer gel (fibrin). As controls, we have tested the redifferentiation of chondrocytes in cell aggregates, and we have checked the proper functionality of chambers both in vitro and in vivo. After retrieval, firmed tissue-like shapes were recovered only from chambers containing cells seeded in membranes. Histomorphological, immunohistochemical, and ultrastructural analyses revealed synthesis of fibrous-like tissue, characterized by low-density collagen fibers, low collagen type II, abundant collagen type I, and low amounts of proteoglycans. Additionally, neither the collagen membranes nor the fibrin gel was reabsorbed by cells. In summary, our results show that the newly developed permeable chambers function correctly, allowing proper cell feeding and preventing cell leakage or host cell invasion. Additionally, our results suggest that, under these circumstances, chondrocytes are not able to orchestrate formation of hyaline cartilage and have little capacity to degrade artificial membranes or carrier gels such as fibrin. These are interesting observations that should be considered for understanding what role the transplanted chondrocytes play during restoration of articular cartilage after implantation.
在单层培养中,移植软骨细胞对软骨组织修复的确切贡献尚未确定。在我们的实验室,我们创造了一个新的可渗透室,用于研究在封闭和控制的环境中异位植入的去分化细胞的软骨形成。软骨细胞的行为已经在移植过程中经常使用的临床方法中进行了研究,即注射悬浮中的自体软骨细胞(ACI),浸泡在胶原膜中的细胞(MACI),以及应用于聚合物凝胶(纤维蛋白)中的细胞。作为对照,我们在细胞聚集体中测试了软骨细胞的再分化,并在体外和体内检查了腔室的正常功能。回收后,仅从含有膜内细胞的腔室中恢复了固定的组织样形状。组织形态学、免疫组织化学和超微结构分析显示合成了纤维样组织,其特征是低密度胶原纤维、低II型胶原、丰富的I型胶原和低量的蛋白多糖。此外,胶原膜和纤维蛋白凝胶都没有被细胞重吸收。总之,我们的研究结果表明,新开发的渗透腔功能正确,允许适当的细胞摄食,防止细胞渗漏或宿主细胞入侵。此外,我们的研究结果表明,在这种情况下,软骨细胞不能协调透明软骨的形成,并且几乎没有能力降解人工膜或纤维蛋白等载体凝胶。这些有趣的观察结果对于理解移植的软骨细胞在植入后关节软骨的修复中所起的作用是值得考虑的。
{"title":"Behavior of Human Articular Chondrocytes During In Vivo Culture in Closed, Permeable Chambers.","authors":"I. Martinez-Zubiaurre, Tuija Annala, M. Polacek","doi":"10.3727/215517912X647226","DOIUrl":"https://doi.org/10.3727/215517912X647226","url":null,"abstract":"The exact contribution of transplanted chondrocytes for cartilage tissue repair prior expansion in monolayer culures remains undetermined. At our laboratory, we have created a new permeable chamber to study the chondrogenesis of dedifferentiated cells implanted ectopically in a closed and controlled environment. The behavior of chondrocytes has been studied in settings frequently used in clinical approaches during transplantation, namely injection of autologous chondrocyte cells in suspension (ACI), cells soaked in collagen membranes (MACI), and cells applied in a polymer gel (fibrin). As controls, we have tested the redifferentiation of chondrocytes in cell aggregates, and we have checked the proper functionality of chambers both in vitro and in vivo. After retrieval, firmed tissue-like shapes were recovered only from chambers containing cells seeded in membranes. Histomorphological, immunohistochemical, and ultrastructural analyses revealed synthesis of fibrous-like tissue, characterized by low-density collagen fibers, low collagen type II, abundant collagen type I, and low amounts of proteoglycans. Additionally, neither the collagen membranes nor the fibrin gel was reabsorbed by cells. In summary, our results show that the newly developed permeable chambers function correctly, allowing proper cell feeding and preventing cell leakage or host cell invasion. Additionally, our results suggest that, under these circumstances, chondrocytes are not able to orchestrate formation of hyaline cartilage and have little capacity to degrade artificial membranes or carrier gels such as fibrin. These are interesting observations that should be considered for understanding what role the transplanted chondrocytes play during restoration of articular cartilage after implantation.","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"4 2 1","pages":"99-107"},"PeriodicalIF":0.0,"publicationDate":"2012-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517912X647226","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69756180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Comparison of Gingiva, Dental Pulp, and Periodontal Ligament Cells From the Standpoint of Mesenchymal Stem Cell Properties. 从间充质干细胞特性的角度比较牙龈、牙髓和牙周韧带细胞。
Pub Date : 2012-04-01 DOI: 10.3727/215517912X653319
Koji Otabe, T. Muneta, N. Kawashima, H. Suda, K. Tsuji, I. Sekiya
The specific properties of mesenchymal stem cells (MSCs) in oral tissues still remain unknown though their existence has been previously reported. We collected gingiva, dental pulp, and periodontal ligament tissues from removed teeth and isolated MSCs. These MSCs were compared in terms of their yields per tooth, surface epitopes, and differentiation potentials by patient-matched analysis. For in vivo calcification analysis, rat gingival and dental pulp cells mounted on β-tricalcium phospateTCP were transplanted into the perivertebral muscle of rats for 6 weeks. Gingival cells and dental pulp cells showed higher yield per tooth than periodontal ligament cells (n=6, p<0.05). Yields of periodontal ligament cells were too low for further analysis. Gingival and dental pulp cells expressed MSC markers such as CD44, CD90, and CD166. Gingival and dental pulp cells obtained phenotypes of chondrocytes and adipocytes in vitro. Approximately 60% of the colonies of gingival cells and 40% of the colonies of dental pulp cells were positively stained with alizarin red in vitro, and both gingival and dental pulp cells were calcified in vivo. We clarified properties of MSCs derived from removed teeth. We could obtain a high yield of MSCs with osteogenic potential from gingiva and dental pulp. These results indicate that gingiva and dental pulp are putative cell sources for hard tissue regeneration.
间充质干细胞(MSCs)在口腔组织中的具体特性虽然以前有报道,但仍不清楚。我们从移除的牙齿和分离的间充质干细胞中收集牙龈、牙髓和牙周韧带组织。通过患者匹配分析,比较这些间充质干细胞的每颗牙齿产量、表面表位和分化潜力。为了进行体内钙化分析,将装载于β-磷酸三钙etcp上的大鼠牙龈和牙髓细胞移植到大鼠椎周围肌肉中6周。龈细胞和牙髓细胞单牙产量显著高于牙周韧带细胞(n=6, p<0.05)。牙周韧带细胞的产量太低,无法进一步分析。牙龈和牙髓细胞表达MSC标志物,如CD44、CD90和CD166。牙龈和牙髓细胞在体外获得软骨细胞和脂肪细胞的表型。在离体实验中,大约60%的牙龈细胞和40%的牙髓细胞被茜素红染色呈阳性,在体实验中,牙龈和牙髓细胞均发生钙化。我们阐明了从脱落的牙齿中提取的间充质干细胞的性质。我们可以从牙龈和牙髓中获得高产的具有成骨潜能的间充质干细胞。这些结果表明,牙龈和牙髓可能是硬组织再生的细胞来源。
{"title":"Comparison of Gingiva, Dental Pulp, and Periodontal Ligament Cells From the Standpoint of Mesenchymal Stem Cell Properties.","authors":"Koji Otabe, T. Muneta, N. Kawashima, H. Suda, K. Tsuji, I. Sekiya","doi":"10.3727/215517912X653319","DOIUrl":"https://doi.org/10.3727/215517912X653319","url":null,"abstract":"The specific properties of mesenchymal stem cells (MSCs) in oral tissues still remain unknown though their existence has been previously reported. We collected gingiva, dental pulp, and periodontal ligament tissues from removed teeth and isolated MSCs. These MSCs were compared in terms of their yields per tooth, surface epitopes, and differentiation potentials by patient-matched analysis. For in vivo calcification analysis, rat gingival and dental pulp cells mounted on β-tricalcium phospateTCP were transplanted into the perivertebral muscle of rats for 6 weeks. Gingival cells and dental pulp cells showed higher yield per tooth than periodontal ligament cells (n=6, p<0.05). Yields of periodontal ligament cells were too low for further analysis. Gingival and dental pulp cells expressed MSC markers such as CD44, CD90, and CD166. Gingival and dental pulp cells obtained phenotypes of chondrocytes and adipocytes in vitro. Approximately 60% of the colonies of gingival cells and 40% of the colonies of dental pulp cells were positively stained with alizarin red in vitro, and both gingival and dental pulp cells were calcified in vivo. We clarified properties of MSCs derived from removed teeth. We could obtain a high yield of MSCs with osteogenic potential from gingiva and dental pulp. These results indicate that gingiva and dental pulp are putative cell sources for hard tissue regeneration.","PeriodicalId":9780,"journal":{"name":"Cell medicine","volume":"4 1 1","pages":"13-21"},"PeriodicalIF":0.0,"publicationDate":"2012-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3727/215517912X653319","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69755749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
期刊
Cell medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1